Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal dexmedetomidine vs oral chloral hydrate for EEG sedation
IRCT20210614051574N8Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and chloral hydrate (2 arms), sponsored by Isfahan University of Medical Sciences. Started Mar 2022; status: completed.
02
Drugs
dexmedetomidinechloral hydrate
Beyond the preview
Go deeper on IRCT20210614051574N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210614051574N8.